Last reviewed · How we verify
A Randomized, Double-blind, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Patients With Type 2 Diabetes and Inadequate Glycemic Control ; Phase III Study
The aim of this study is to evaluate the efficacy and safety fo CJ-30001/CJ-30002.
Details
| Lead sponsor | HK inno.N Corporation |
|---|---|
| Phase | Phase 3 |
| Status | COMPLETED |
| Enrolment | 187 |
| Start date | 2011-04 |
| Completion | 2012-07 |
Conditions
- Diabetes Mellitus
Interventions
- Metformin
- CJ-30001/CJ-30002
Primary outcomes
- Change from baseline in HbA1c at week 24 — Baseline, week 24
Countries
South Korea